Umea, Sweden

Umecrine Ab


USPTO Granted Patents = 6

% Expired Patents = 83.3



Forward Citations = 16

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Torbjörn Bäckström (6 out of 16 patents)

silverMedal Ming-De Wang (4 out of 5 patents)

bronzeMedal Per Lundgren (4 out of 4 patents)

4 Gianna Ragagnin (2 out of 4 patents)

5 Inga-Maj Johansson (2 out of 2 patents)

6 Torbjorn Backstrom (0 patent)

7 Torbjoern Baeckstroem (0 patent)

8 Ming-De Wang (0 patent)

9 Per Lundgren (0 patent)


6 patents:

Umecrine AB is a clinical stage pharmaceutical company focused on developing novel treatments for stress-related and related conditions. The company's lead candidate, GR3027, aims to address the unmet medical need for effective drugs in gastroenterology and psychiatry by targeting the Cortisol Receptor Modulator (CRMC) system. With a strong pipeline of innovative drug candidates, Umecrine is committed to improving the lives of patients suffering from stress-related disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

6 Patents

#6 in Umea

#926 in Sweden

Umea, SE
Umea, Sweden
Forward Citations = 16

5 inventors:

Please report any incorrect information to [email protected]
Loading…